Home Search Contact Print

Products Ordering Technology Publications News Company

DNA/RNA Aptamer Microarray Service

 

Submit a Sample

 

Additional Information

Scientific Publications

Application Notes

 

 

Signup

e-Newsletter

 

Application Articles  (Aptamer Oligonucleotide Microarrays)

  1. Baldrich, E., Acero, J. L., Reekmans, G., Laureyn, W., O'sullivan, C, K. (2005) Displacement Enzyme Linked Aptamer Assay. Anal. Chem. 77, 4774-4784. [ abstract]
  2. Bielinska, A., Shivdasani, R.A., Zhang, L.Q. and Nabel, G.J. (1990) Regulation of gene expression with double-stranded phosphorothioate oligonucleotides. Science, 250, 997-1000. [ abstract]
  3. Brody, E. N., Gold, L. (2000) Aptamers as therapeutic and diagnostic agents. J. Biotechnol., 74, 5-13. [ abstract]
  4. Bruno, J. G., Kiel, J. L. (1999) In vitro selection of DNA aptamers to anthrax spores with electrochemiluminescence detection. Biosens. Bioelectron., 14, 457-464. [ abstract]
  5. Burke, D.H., Scates, L., Andrews, K. and Gold, L. (1996) Bent Pseudoknots and Novel RNA Inhibitors of Type 1 Human Immunodeficiency Virus (HIV-1) Reverse Transcriptase. J. Mol. Biol., 264, 650-666. [ abstract]
  6. Burmeister, P. E., Lewis, S. D., Silva, R. F., Preiss, J. R., Horwitz, L. R., Pendergrast, P. S., McCauley, T. G., Kurz, J. C., Epstein, D. M., Wilson, C., Keefe, A. D. (2005) Direct in vitro selection of a 2'-O-methyl aptamer to VEGF. Chem. Biol. 12, 25-33. [ abstract]
  7. Burgstaller, P., Jenne, A., and Blind, M. (2002) Aptamers and aptazymes: accelerating small molecule drug discovery. Curr. Opin. Drug Discov. Devel. 5, 690-700. [ abstract]
  8. Cassiday, L. A., Maher, L. J. 3rd.(2001) In vivo recognition of an RNA aptamer by its transcription factor target. Biochemistry 40, 2433-2438. [ abstract]
  9. Chen, H. and Gold, L. (1994) Selection of high-affinity RNA ligands to reverse transcriptase, Inhibition of cDNA synthesis and RNase H activity, Biochemistry, 33, 8746-8756. [ abstract]
  10. Cong, X., Nilsen-Hamilton, M. (2005) Allosteric aptamers: targeted reversibly attenuated probes. Biochemistry 44, 7945-7954. [ abstract]
  11. Darfeuille, F., Hansen, J. B., Orum, H., Di Primo, C., Toulme, J. J. (2004) LNA/DNA chimeric oligomers mimic RNA aptamers targeted to the TAR RNA element of HIV-1. Nucleic Acids Res. 32, 3101-3107. [ abstract] [ article]
  12. Di Giusto, D. A., Wlassoff, W. A., Gooding, J. J., Messerle, B. A., King, G. C. (2005) Proximity extension of circular DNA aptamers with real-time protein detection. Nucleic Acids Res. 33, e64. [ abstract] [ article]
  13. Ellington, A. D., and Szostak, J. W. (1990) In vitro selection of RNA molecules that bind specific ligands. Nature 346, 818-822. [ abstract]
  14. Erratum:  Nucleic Acids Res. 32, 3512.
  15. Famulok, M., Jenne, A. (1998) Oligonucleotide libraries--variatio delectat. Curr. Opin. Chem. Biol. 2, 320-327. [ abstract]
  16. Ghosh, G., Huang, D. B., Huxford, T. (2004) Molecular mimicry of the NF-kappaB DNA target site by a selected RNA aptamer. Curr. Opin. Struct. Biol. 14, 21-27. [ abstract]
  17. Gold, L., Brown, D., He, Y.Y., Shtatland, T., Singer, B.S. and Wu, Y. (1997) From oligonucleotide shapes to genomic Selex - novel biological regulatory loops, Proc. Natl. Acad. Sci. U.S.A., 94, 59-64. [ abstract] [ article]
  18. Gold, L., Polisky, B., Uhlenbeck, O. and Yarus, M. (1995) Diversity of oligonucleotide functions, Annu. Rev. Biochem., 64, 763-797. [ abstract]
  19. Huang, D. B., Vu, D., Cassiday, L. A., Zimmerman, J. M., Maher, L. J. 3rd, Ghosh, G. (2003) Crystal structure of NF-kappaB (p50)2 complexed to a high-affinity RNA aptamer. Proc. Natl. Acad. Sci. USA 100, 9268-9273. [ abstract] [ article]
  20. Kim, Y. M., Choi, K. H., Jang, Y. J., Yu, J., Jeong, S. (2003) Specific modulation of the anti-DNA autoantibody-nucleic acids interaction by the high affinity RNA aptamer. Biochem. Biophys. Res. Commun. 300, 516-523. [abstract]
  21. Kirby, R., Cho, E. J., Gehrke, B., Bayer, T., Park, Y. S., Neikirk, D. P., McDevitt, J. T., Ellington, A. D. (2004) Aptamer-based sensor arrays for the detection and quantitation of proteins. Anal. Chem., 76, 4066-4075. [abstract]
  22. Latham, J. A., Johnson, R., Toole, J. J. (1994) The application of a modified nucleotide in aptamer selection: novel thrombin aptamers containing 5-(1-pentynyl)-2'-deoxyuridine. Nucleic Acids Res. 22, 2817-2822. [ abstract] [ article]
  23. Lebruska, L.L. and Maher, I.L.J. (1999) Selection and Characterization of an RNA Decoy for Transcription Factor NF-kappaB.  Biochemistry, 38, 3168-3174. [ abstract]
  24. McCauley, T. G., Hamaguchi, N. and Stanton, M. (2003) Aptamer-based biosensor arrays for detection and quantification of biological macromolecules. Anal. Biochem., 319, 244-250. [ abstract]
  25. Murphy, MB., Fuller, S. T., Richardson, P. M., and Doyle, S. A. (2003) An improved method for the in vitro evolution of aptamers and applications in protein detection and purification. Nucleic Acids Res. 31, e110. [abstract] [ article]
  26. Nutiu, R., Li, Y. (2003) Structure-switching signaling aptamers. J. Am. Chem. Soc. 125, 4771-4778. [ abstract]
  27. Park, M. W., Choi, K. H., Jeong, S. (2005) Inhibition of the DNA binding by the TCF-1 binding RNA aptamer. Biochem. Biophys. Res. Commun. 330, 11-17. [ abstract]
  28. Park, Y.G., Nesterova, M., Agrawal, S. and Cho-Chung, Y.S. (1999) Dual blockade of cyclic aMP fesponse element-(CRE) and AP-1directed Transcription by CRE-transcription factor decoy oligonucleotide.  J. Biol. Chem., 274, 1573-1580. [abstract]
  29. Pestourie, C., Tavitian, B., Duconge, F. (2005) Aptamers against extracellular targets for in vivo applications. Biochimie. Jun 14 [Epub ahead of print]. [ abstract]
  30. Proske, D., Gilch, S., Wopfner, F., Schatzl, H. M., Winnacker, E. L., Famulok, M. (2002) Prion-protein-specific aptamer reduces PrPSc formation. Chembiochem 3, 717-725. [ abstract]
  31. Rhodes, A., Deakin, A., Spaull, J., Coomber, B., Aitken, A., Life, P., Rees, S. (2000) The generation and characterization of antagonist RNA aptamers to human oncostatin M. J. Biol. Chem. 275, 28555-28561. [ abstract] [article]
  32. Roberts, R. W., Ja, W. W. (1999) In vitro selection of nucleic acids and proteins: what are we learning? Curr. Opin. Str. Biol. 9, 521–529. [ abstract]
  33. Sayer, N. M., Cubin, M., Rhie, A., Bullock, M., Tahiri-Alaoui, A., James, W. Structural determinants of conformationally selective, prion-binding aptamers. J. Biol. Chem. 279, 13102-13109. [ abstract]  [article]
  34. Schmidt, K. S., Borkowski, S., Kurreck, J., Stephens, A. W., Bald, R., Hecht, M., Friebe, M., Dinkelborg, L., Erdmann, V. A. (2004) Application of locked nucleic acids to improve aptamer in vivo stability and targeting function. Nucleic Acids Res. 32, 5757-5765. [abstract] [article]
  35. Tahiri-Alaoui, A., Frigotto, L., Manville, N., Ibrahim, J., Romby1, P., James, W. (2002) High affinity nucleic acid aptamers for streptavidin incorporated into bi-specific capture ligands. Nucleic Acids Res., 30, e45. [ abstract] [ article]
  36. Tomita, N., Morishita, R., Higaki, J. and Ogihara, T. (1997) A novel strategy for gene therapy and gene regulation analysis using transcription factor decoy oligonucleotides. Exp. Nephrol. 5, 429-434. [ abstract]
  37. Toulme, J. J., Di Primo, C., Boucard, D. (2004) Regulating eukaryotic gene expression with aptamers. FEBS Lett. 567, 55-62. [ abstract]
  38. Tuerek, C., and Gold, L. (1990) Systematic evolution of ligands by exponential enrichment, RNA ligands to bacteriophage T4 DNA polymerase. Science, 249, 505-510. [ abstract]
  39. Yang, X-B., and Gorenstein, D. G. (2004) Progress in thioaptamer development. Curr. Drug Targets, 5, 705-715 (and references cited therein). [ abstract]
  40. Zhang, Z., Blank, M., Schluesener, H, J. (2004) Nucleic acid aptamers in human viral disease. Arch. Immunol. Ther. Exp. (Warsz) 52, 307-315. [ abstract]

 

Sitemap • Privacy • Terms of Use • Disclaimer

Copyright © 2008, LC Sciences